SilverCrest Metals
SILV
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
Cars.com
CARS
Halozyme Therapeutics
HALO
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -0.09%352M | 7.26%319.3M | 43.55%364.9M | 21.90%370.7M | 21.90%370.7M | 52.05%352.3M | 17.53%297.7M | 16.39%254.2M | 13.94%304.1M | 13.94%304.1M |
-Cash and cash equivalents | -0.09%352M | 7.26%319.3M | 43.55%364.9M | 21.90%370.7M | 21.90%370.7M | 52.05%352.3M | 17.53%297.7M | 16.39%254.2M | 13.94%304.1M | 13.94%304.1M |
Receivables | 3.86%670M | 5.61%719.4M | 8.76%685.3M | 0.05%547.8M | 0.05%547.8M | 21.46%645.1M | 21.88%681.2M | 19.88%630.1M | 7.84%547.5M | 7.84%547.5M |
-Accounts receivable | 3.86%670M | 5.61%719.4M | 8.76%685.3M | 0.05%547.8M | 0.05%547.8M | 21.46%645.1M | 21.88%681.2M | 19.88%630.1M | 7.84%547.5M | 7.84%547.5M |
Inventory | 9.40%1.22B | 9.88%1.23B | 12.41%1.22B | 19.99%1.19B | 19.99%1.19B | 13.84%1.12B | 16.49%1.12B | 17.57%1.08B | 21.50%988.4M | 21.50%988.4M |
Other current assets | 5.30%137M | 11.29%130.1M | -0.90%121.8M | 15.33%140.7M | 15.33%140.7M | 5.77%130.1M | -12.63%116.9M | -27.62%122.9M | -32.11%122M | -32.11%122M |
Total current assets | 6.08%2.38B | 8.29%2.4B | 14.31%2.39B | 14.43%2.25B | 14.43%2.25B | 20.22%2.24B | 16.16%2.22B | 13.91%2.09B | 10.99%1.96B | 10.99%1.96B |
Non current assets | ||||||||||
Net PPE | 20.28%602M | 17.08%574.5M | 19.80%573.7M | 22.38%569.8M | 22.38%569.8M | 11.12%500.5M | 11.07%490.7M | 10.37%478.9M | 8.38%465.6M | 8.38%465.6M |
-Gross PPE | 18.42%1.07B | 15.05%1.02B | 15.75%1.01B | 17.24%995M | 17.24%995M | 7.88%901.9M | 6.54%887.6M | 5.80%871.6M | 3.91%848.7M | 3.91%848.7M |
-Accumulated depreciation | -16.09%-466M | -12.55%-446.7M | -10.82%-435.2M | -10.99%-425.2M | -10.99%-425.2M | -4.10%-401.4M | -1.43%-396.9M | -0.72%-392.7M | 1.06%-383.1M | 1.06%-383.1M |
Goodwill and other intangible assets | 4.79%315M | -0.81%305.4M | 0.92%306.8M | 2.82%310.3M | 2.82%310.3M | 3.44%300.6M | 10.20%307.9M | 5.52%304M | 2.83%301.8M | 2.83%301.8M |
-Goodwill | 5.69%301M | 0.07%291.3M | 1.67%292M | 3.59%294.6M | 3.59%294.6M | 4.28%284.8M | 8.86%291.1M | 4.28%287.2M | 1.54%284.4M | 1.54%284.4M |
-Other intangible assets | -11.39%14M | -16.07%14.1M | -11.90%14.8M | -9.77%15.7M | -9.77%15.7M | -9.71%15.8M | 40.00%16.8M | 32.28%16.8M | 29.85%17.4M | 29.85%17.4M |
Other non current assets | 16.25%483M | 24.87%498M | 20.08%489.8M | 26.11%490.2M | 26.11%490.2M | 12.75%415.5M | 9.77%398.8M | 6.56%407.9M | 4.32%388.7M | 4.32%388.7M |
Total non current assets | 15.07%1.4B | 15.07%1.38B | 15.07%1.37B | 18.53%1.37B | 18.53%1.37B | 9.65%1.22B | 10.41%1.2B | 7.78%1.19B | 5.51%1.16B | 5.51%1.16B |
Total assets | 9.24%3.78B | 10.67%3.78B | 14.59%3.76B | 15.95%3.62B | 15.95%3.62B | 16.28%3.46B | 14.08%3.42B | 11.61%3.28B | 8.89%3.12B | 8.89%3.12B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -11.27%593M | 1.94%703.7M | 1.83%699.3M | 12.49%702.6M | 12.49%702.6M | 13.39%668.3M | 14.17%690.3M | 20.16%686.7M | 16.16%624.6M | 16.16%624.6M |
-accounts payable | -11.27%593M | 1.94%703.7M | 1.83%699.3M | 12.49%702.6M | 12.49%702.6M | 13.39%668.3M | 14.17%690.3M | 20.16%686.7M | 16.16%624.6M | 16.16%624.6M |
Current debt and capital lease obligation | 66.67%4M | 41.67%3.4M | 52.38%3.2M | 47.37%2.8M | 47.37%2.8M | 26.32%2.4M | 14.29%2.4M | 10.53%2.1M | -66.07%1.9M | -66.07%1.9M |
-Current debt | 66.67%4M | 41.67%3.4M | 52.38%3.2M | 47.37%2.8M | 47.37%2.8M | 26.32%2.4M | 14.29%2.4M | 10.53%2.1M | -66.07%1.9M | -66.07%1.9M |
Other current liabilities | -25.91%290M | -25.91%282.2M | 11.34%402.7M | 3.38%278.2M | 3.38%278.2M | 24.61%391.4M | 28.73%380.9M | 4.51%361.7M | 4.26%269.1M | 4.26%269.1M |
Current liabilities | -6.22%996M | 1.33%1.09B | 5.21%1.11B | 12.08%1.12B | 12.08%1.12B | 11.48%1.06B | 12.42%1.07B | 14.25%1.05B | 9.75%998.6M | 9.75%998.6M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -21.78%624M | -9.82%662.2M | -6.97%720.9M | -19.80%620.4M | -19.80%620.4M | -3.26%797.7M | -11.11%734.3M | 4.94%774.9M | 15.72%773.6M | 15.72%773.6M |
-Long term debt | -11.65%624M | -9.82%662.2M | -6.97%720.9M | -19.80%620.4M | -19.80%620.4M | -14.35%706.3M | -11.11%734.3M | 4.94%774.9M | 15.72%773.6M | 15.72%773.6M |
-Long term capital lease obligation | ---- | ---- | ---- | ---- | ---- | --91.4M | ---- | ---- | ---- | ---- |
Other non current liabilities | 94.10%204M | 17.36%205.5M | 25.25%201.9M | 23.62%203.6M | 23.62%203.6M | -36.11%105.1M | 6.96%175.1M | -3.99%161.2M | -6.15%164.7M | -6.15%164.7M |
Total non current liabilities | -8.29%828M | -4.59%867.7M | -1.42%922.8M | -12.18%824M | -12.18%824M | -8.73%902.8M | -8.12%909.4M | 3.29%936.1M | 11.17%938.3M | 11.17%938.3M |
Total liabilities | -7.17%1.82B | -1.38%1.96B | 2.08%2.03B | 0.33%1.94B | 0.33%1.94B | 1.19%1.96B | 1.96%1.98B | 8.81%1.99B | 10.43%1.94B | 10.43%1.94B |
Shareholders'equity | ||||||||||
Share capital | 11.11%1M | 0.00%900K | 0.00%900K | 0.00%900K | 0.00%900K | 0.00%900K | 0.00%900K | 0.00%900K | 0.00%900K | 0.00%900K |
-common stock | 11.11%1M | 0.00%900K | 0.00%900K | 0.00%900K | 0.00%900K | 0.00%900K | 0.00%900K | 0.00%900K | 0.00%900K | 0.00%900K |
Retained earnings | 26.77%1.98B | 30.91%1.9B | 35.98%1.77B | 39.50%1.67B | 39.50%1.67B | 39.57%1.56B | 39.00%1.45B | 33.02%1.3B | 28.15%1.2B | 28.15%1.2B |
Paid-in capital | 2.93%914M | 3.40%909M | 3.59%900.1M | 2.78%906.1M | 2.78%906.1M | 1.60%888M | 1.40%879.1M | 0.95%868.9M | 2.51%881.6M | 2.51%881.6M |
Less: Treasury stock | 10.27%656M | 8.34%644.1M | 11.03%624.9M | 11.08%622.4M | 11.08%622.4M | 6.94%594.9M | 9.54%594.5M | 17.62%562.8M | 21.88%560.3M | 21.88%560.3M |
Gains losses not affecting retained earnings | 21.91%-279M | -12.25%-342.7M | -0.19%-315.9M | 15.95%-287.1M | 15.95%-287.1M | 10.96%-357.3M | 4.86%-305.3M | -26.88%-315.3M | -49.50%-341.6M | -49.50%-341.6M |
Total stockholders'equity | 30.80%1.96B | 27.35%1.82B | 33.78%1.73B | 41.58%1.67B | 41.58%1.67B | 44.60%1.5B | 36.54%1.43B | 16.20%1.29B | 6.45%1.18B | 6.45%1.18B |
Total equity | 30.80%1.96B | 27.35%1.82B | 33.78%1.73B | 41.58%1.67B | 41.58%1.67B | 44.60%1.5B | 36.54%1.43B | 16.20%1.29B | 6.45%1.18B | 6.45%1.18B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |